Systemically administered VEGF pathway inhibitors: risk of aneurysm and artery dissection
Healthcare professionals are advised to carefully consider the risk and reduce as far as possible any modifiable risk factors
Published
Join OnMedica and benefit from:
- Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
- High-quality, evidence-based content developed by expert editors and clinicians
- Articles, quizzes, videos, visual summaries and more
- Regulatory alerts and round-up of medical journals
- New content added daily, so you know you’re always up to date
No comments yet.